- Approval Id
- d32d8ac900be6736
- Drug Name
- DHASOLONE TABLET 5 mg
- Product Name
- DHASOLONE TABLET 5 mg
- Approval Number
- SIN04207P
- Approval Date
- 1990-04-16
- Registrant
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Licence Holder
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET
- Dosage
- **RECOMMENDED DOSES:**
Orally administered:
Dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.
Adults : 5–60 mg daily in divided doses or as a single daily or double dose on alternate days.
In long term therapy, dosage should be maintained at not more than 7 mg daily whenever possible.
Children: As directed by physician.
For short term treatment of not more than 2 weeks, as it may lead to growth retardation in children.
- Route Of Administration
- ORAL
- Indication Info
- **INDICATIONS:**
For the suppression of inflammatory and allergic disorders and for the treatment of conditions for which corticosteroid therapy is indicated except in adrenal-deficiency states.
- Contraindications
- **CONTRA-INDICATIONS:**
Patients with active or doubtfully quiescent tuberculosis. In the presence of acute infections, including herpes zoster and herpes simplex, ulceration of the eye. Patients with peptic ulcer, osteoporosis, pyschoses or severe psychoneuroses.
- Atc Code
- H02AB06
- Atc Item Name
- prednisolone
- Pharma Manufacturer Name
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Company Detail Path
- /organization/teva-pharmaceutical-investments-singapore-pte-ltd
